Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

Also called NCT03602742

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Sigknow Biomedical Co., Ltd. (from the registry)
Registry
  • NCT NCT03602742
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03602742. Allocation not applicable; no masking; primary purpose diagnostic. Start 2018-03-16 (actual); primary completion 2018-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO
Condition
Arrhythmias, Cardiac
Intervention (Device)
EZYPRO®
Lead sponsor
Sigknow Biomedical Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct03602742
Content hash
a704662dec18029dc851c1536ccda922a081bf9f92e9de0a2b07e438d52f4164